Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The impact of MeCP2 loss- or gain-of-function on synaptic plasticity.

Na ES, Nelson ED, Kavalali ET, Monteggia LM.

Neuropsychopharmacology. 2013 Jan;38(1):212-9. doi: 10.1038/npp.2012.116. Epub 2012 Jul 11. Review.

2.

Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.

Monteggia LM, Kavalali ET.

Biol Psychiatry. 2009 Feb 1;65(3):204-10. doi: 10.1016/j.biopsych.2008.10.036. Epub 2008 Dec 5. Review.

3.

The role of MeCP2 in CNS development and function.

Na ES, Monteggia LM.

Horm Behav. 2011 Mar;59(3):364-8. doi: 10.1016/j.yhbeh.2010.05.014. Epub 2010 May 31. Review.

4.

MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.

Kaufmann WE, Johnston MV, Blue ME.

Brain Dev. 2005 Nov;27 Suppl 1:S77-S87. Epub 2005 Sep 22. Review.

PMID:
16182491
5.

BDNF deregulation in Rett syndrome.

Li W, Pozzo-Miller L.

Neuropharmacology. 2014 Jan;76 Pt C:737-46. doi: 10.1016/j.neuropharm.2013.03.024. Epub 2013 Apr 15. Review.

6.

The role of MeCP2 in brain development and neurodevelopmental disorders.

Gonzales ML, LaSalle JM.

Curr Psychiatry Rep. 2010 Apr;12(2):127-34. doi: 10.1007/s11920-010-0097-7. Review.

7.

Experimental models of Rett syndrome based on Mecp2 dysfunction.

Calfa G, Percy AK, Pozzo-Miller L.

Exp Biol Med (Maywood). 2011 Jan;236(1):3-19. doi: 10.1258/ebm.2010.010261. Review.

8.

The molecular pathology of Rett syndrome: synopsis and update.

Akbarian S, Jiang Y, Laforet G.

Neuromolecular Med. 2006;8(4):485-94. Review.

PMID:
17028371
9.

Rett syndrome and MeCP2.

Liyanage VR, Rastegar M.

Neuromolecular Med. 2014 Jun;16(2):231-64. doi: 10.1007/s12017-014-8295-9. Epub 2014 Mar 11. Review.

PMID:
24615633
10.

MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.

Gadalla KK, Bailey ME, Cobb SR.

Biochem J. 2011 Oct 1;439(1):1-14. doi: 10.1042/BJ20110648. Review.

PMID:
21916843
11.

Brain-derived neurotrophic factor and Rett syndrome.

Katz DM.

Handb Exp Pharmacol. 2014;220:481-95. doi: 10.1007/978-3-642-45106-5_18. Review.

PMID:
24668484
12.

MeCP2 dysfunction in Rett syndrome and related disorders.

Moretti P, Zoghbi HY.

Curr Opin Genet Dev. 2006 Jun;16(3):276-81. Epub 2006 May 2. Review.

PMID:
16647848
13.

MECP2 disorders: from the clinic to mice and back.

Lombardi LM, Baker SA, Zoghbi HY.

J Clin Invest. 2015 Aug 3;125(8):2914-23. doi: 10.1172/JCI78167. Epub 2015 Aug 3. Review.

PMID:
26237041
14.

In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system.

Díaz de León-Guerrero S, Pedraza-Alva G, Pérez-Martínez L.

Eur J Neurosci. 2011 May;33(9):1563-74. doi: 10.1111/j.1460-9568.2011.07658.x. Epub 2011 Apr 1. Review.

15.

Evolving role of MeCP2 in Rett syndrome and autism.

LaSalle JM, Yasui DH.

Epigenomics. 2009 Oct;1(1):119-30. doi: 10.2217/epi.09.13. Review.

16.

The neurobiology of Rett syndrome.

Akbarian S.

Neuroscientist. 2003 Feb;9(1):57-63. Review.

PMID:
12580340
17.

The relationship of Rett syndrome and MECP2 disorders to autism.

Neul JL.

Dialogues Clin Neurosci. 2012 Sep;14(3):253-62. Review.

18.

The story of Rett syndrome: from clinic to neurobiology.

Chahrour M, Zoghbi HY.

Neuron. 2007 Nov 8;56(3):422-37. Review.

19.

Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome.

Castro J, Mellios N, Sur M.

Curr Opin Neurol. 2013 Apr;26(2):154-9. doi: 10.1097/WCO.0b013e32835f19a7. Review.

PMID:
23449173
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk